CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...